|
ZNF638 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.27300000000308E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.060100E-03 |
| Normal-vs-Stage2 |
4.078600E-03 |
| Normal-vs-Stage3 |
1.61077999999426E-05 |
| Normal-vs-Stage4 |
9.774000E-04 |
| Stage1-vs-Stage2 |
2.408200E-01 |
| Stage1-vs-Stage3 |
1.501500E-02 |
| Stage1-vs-Stage4 |
6.945600E-02 |
| Stage2-vs-Stage3 |
5.777400E-01 |
| Stage2-vs-Stage4 |
6.463600E-01 |
| Stage3-vs-Stage4 |
9.942200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.66654999999016E-05 |
| Normal-vs-AfricanAmerican |
1.791360E-01 |
| Normal-vs-Asian |
5.072200E-01 |
| Caucasian-vs-AfricanAmerican |
2.112400E-01 |
| Caucasian-vs-Asian |
6.860100E-03 |
| AfricanAmerican-vs-Asian |
4.796000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.257100E-03 |
| Normal-vs-Female |
4.38059999999796E-05 |
| Male-vs-Female |
2.978600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.080700E-03 |
| Normal-vs-Age(41-60Yrs) |
2.445400E-04 |
| Normal-vs-Age(61-80Yrs) |
1.230850E-04 |
| Normal-vs-Age(81-100Yrs) |
5.732100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.157200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.915700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.251400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.030400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.746200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.293800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.169510E-04 |
| Classical-VS-Follicular |
5.042600E-01 |
| Classical-VS-Other |
8.752800E-01 |
| Classical-VS-Normal |
6.178200E-03 |
| Tall-VS-Follicular |
1.861190E-03 |
| Tall-VS-Other |
2.722400E-02 |
| Tall-VS-Normal |
2.81919999567393E-08 |
| Follicular-VS-Other |
7.409200E-01 |
| Follicular-VS-Normal |
1.083770E-02 |
| Other-VS-Normal |
3.629600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.622800E-04 |
| Normal-vs-N1 |
3.057700E-03 |
| N0-vs-N1 |
5.316800E-01 |
|
|
